The question as to whether to biopsy small renal masses or not is debated by two kidney cancer experts; Professor Jaime Landman from University of California Irvine Medical Centre in the US, and Professor Michael Staehler from the Ludwig- Maximilian University in Munich, Germany. The experts discuss whether patients with small renal masses should be biopsied, or diagnosed using exclusively imaging. The case is made by Professor Jaime to consider why this is the only cancer that is not routinely biopsied. The experts discuss why the approach in small renal masses is unique.
Listen to the podcast on UroToday here
The following presentations on UroToday present the case for and against biopsy of small renal masses:
Biopsy of the Small Renal Mass – Still Controversial?
Renal Biopsy Cell Cycle Proliferation (CCP) Score Predicts Adverse Surgical Pathology in Renal Cell Carcinoma
Does Renal Biopsy Make Sense in View of Tumor Heterogeneity?
Debate: What is the Role of Biopsy in the Management of the Small Renal Mass?
Automated Digital Analysis of Renal Core Biopsy Specimens Using a Deep-Learning Artificial Intelligence Network